Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion

Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Value

Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs

FDA approves new Alzheimer's treatment, donanemab from Eli Lilly